These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23414670)

  • 1. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
    Gao FQ; Pettersen JA; Bocti C; Nestor SM; Kiss A; Black SE
    Neurobiol Aging; 2013 Jul; 34(7):1807-14. PubMed ID: 23414670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease.
    Jaswal G; Swardfager W; Gao FQ; Nestor SM; Ganda A; Cogo-Moreira H; Sahlas DJ; Stuss DT; Moody A; Black SE
    Neurobiol Aging; 2018 Jun; 66():23-31. PubMed ID: 29505952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region.
    Muth K; Schönmeyer R; Matura S; Haenschel C; Schröder J; Pantel J
    Biol Psychiatry; 2010 Mar; 67(6):588-91. PubMed ID: 19375072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR features of the substantia innominata and therapeutic implications in dementias.
    Hanyu H; Shimizu S; Tanaka Y; Hirao K; Iwamoto T; Abe K
    Neurobiol Aging; 2007 Apr; 28(4):548-54. PubMed ID: 16569466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic subcortical hyperintensities in Alzheimer's disease patients from the Sunnybrook Dementia Study: relationships with cognitive dysfunction and hippocampal atrophy.
    McNeely AA; Ramirez J; Nestor SM; Zhao J; Gao F; Kiss A; Stuss DT; Black SE
    J Alzheimers Dis; 2015; 43(3):785-96. PubMed ID: 25114078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study.
    Colloby SJ; Elder GJ; Rabee R; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):615-623. PubMed ID: 27197956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
    Kim HJ; Moon WJ; Han SH
    J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease.
    Hanyu H; Tanaka Y; Sakurai H; Takasaki M; Abe K
    Neurosci Lett; 2002 Feb; 319(1):33-6. PubMed ID: 11814647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Dos Santos V; Seidl U; Toro P; Essig M; Schröder J
    J Alzheimers Dis; 2009; 17(1):213-21. PubMed ID: 19494444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients.
    Tanaka Y; Hanyu H; Sakurai H; Takasaki M; Abe K
    Dement Geriatr Cogn Disord; 2003; 16(3):119-25. PubMed ID: 12826736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.
    George S; Mufson EJ; Leurgans S; Shah RC; Ferrari C; deToledo-Morrell L
    Neurobiol Aging; 2011 Oct; 32(10):1756-64. PubMed ID: 20005600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status.
    Choi SH; Jung TM; Lee JE; Lee SK; Sohn YH; Lee PH
    Neurobiol Aging; 2012 Jul; 33(7):1265-72. PubMed ID: 21220177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects?
    Moon WJ; Kim HJ; Roh HG; Han SH
    AJNR Am J Neuroradiol; 2008 Aug; 29(7):1308-13. PubMed ID: 18436612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.